protein_complex

Inflammasome Complex

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Inflammasome Complex: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
19Hypotheses
1Analyses
3Outgoing
1Incoming
0Experiments
8Debates

Summary

A multi-protein complex that activates caspase-1-mediated inflammatory responses. The NLRP3 inflammasome is the best-characterized, consisting of NLRP3 sensor, ASC adaptor (PYCARD), and pro-caspase-1. Assembly triggers IL-1β and IL-18 maturation and pyroptotic cell death. NLRP3 inflammasome activation is driven by amyloid-β, α-synuclein, and tau aggregates in neurodegenerative diseases.

Ontology: GO:0061702 · MESH:D000077192

No AI portrait yet

Mechanism Info
NameNLRP3_INFLAMMASOME
Key Genes/ProteinsIL18, IL1B, TREM2
Related Diseasesmicroglial_activation

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

NLRP3 Inflammasome

entity · 1114 words

Outgoing (3)

TargetRelationTypeStr
microglial_activationactivatesphenotype0.70
IL1Bproducesprotein0.64
IL18producesprotein0.64

Incoming (1)

SourceRelationTypeStr
TREM2inhibitsprotein0.72

Targeting Hypotheses (19)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S 0.822 neurodegeneration What are the mechanisms by which gut mic
NLRP3 inflammasome amplification across AD and PD proteinopa 0.800 multi Cross-disease neurodegeneration mechanis
NLRP3 Inflammasome Inhibition for Neuroprotection in Parkins 0.720 neurodegeneration Test
NLRP3 Inflammasome Lock Perpetuates Senescence-Associated In 0.720 neurodegeneration What molecular mechanisms drive microgli
C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macropha 0.631 neuroinflammation What are the specific molecular mechanis
Galectin-3 deletion attenuates NLRP3 inflammasome activation 0.625 neuroscience Lysosomal dysfunction and cathepsin leak
NLRP3 Inflammasome Priming Converts SCFA-Sensitive Pyroptosi 0.620 neurodegeneration How does gut microbiome dysbiosis contri
Selective cathepsin B inhibition prevents cathepsin leakage- 0.620 neuroscience Lysosomal dysfunction and cathepsin leak
NLRP3 Inflammasome Inhibition Prevents Synapse Loss via IL-1 0.610 neurodegeneration Test Preregistration Analysis
Intermittent HBOT (2.0 ATA, 60 min, 3x/week) suppresses NLRP 0.590 neurodegeneration What are the optimal oxygen pressure, du
NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumul 0.566 developmental-neurobiology Do perinatal immune challenges create pe
NLRP3 Inflammasome Blockade as Upstream Intervention to Prev 0.566 neurodegeneration Why have numerous phase 3 clinical trial
P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming 0.563 biomarkers What biomarkers can reliably detect micr
TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inf 0.485 neuroinflammation Immune atlas neuroinflammation analysis
Sub-antidepressant Doses Suppress NLRP3 Inflammasome via P2X 0.465 - What is the minimum effective dose of tr
STING-Mediated NLRP3 Inflammasome Priming in ALS Microglia 0.380 neuroinflammation Immune atlas neuroinflammation analysis
Circulating hs-CRP as Disease-Modifying Target via Astrocyti 0.380 immunomics Systemic immune profiling in neurodegene
NLRP3 Inflammasome Suppression via Selective Caspase-1 Inhib 0.105 neurodegeneration Neuroinflammation Biomarker Panel for Ea
Microglial NLRP3 Inflammasome as Circadian-Specific Drug Tar 0.000 - Can circadian interventions selectively

Mentioning Analyses (1)

Scientific analyses that reference this entity

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

neurodegeneration | 2026-04-03 | 19 hypotheses Top: 0.891

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (9)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Interaction between autophagy and the NLRP3 inflammasome in Alzheimer's and Park [PMID:36262883] Unknown Frontiers in aging neuroscienc 2023 0
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438] Hegdekar N, Sarkar C, Bustos S, Ritzel R Autophagy 2023 0
Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's [PMID:37029500] Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH, Aging cell 2023 0
Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like [PMID:36288697] Li S, Fang Y, Zhang Y, Song M, Zhang X, Cell reports 2022 0
Biomarker of Neuroinflammation in Parkinson's Disease. [PMID:35456966] Liu TW, Chen CM, Chang KH Int J Mol Sci 2022 0
NLRP3 inflammasome activation drives tau pathology. [PMID:31748742] ["Ising C", "Venegas C", "Zhang S", "Sch Nature 2019 0
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407] Gordon R, Albornoz EA, Christie DC, Lang Science translational medicine 2018 0
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS [PMID:23254930] Heneka MT, Kummer MP, Stutz A, Delekate Nature 2013 0
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS [PMID:23254930] ["Heneka Michael T", "Kummer Markus P", Nature 2013 0

Debates (8)

Multi-agent debates referencing this entity

Second debate: Microglial TREM2-SYK Pathway Enhancement

closed · Rounds: 4 · Score: 0.57 · 2026-04-28

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

closed · Rounds: 4 · Score: 0.12 · 2026-04-27

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

closed · Rounds: 4 · Score: 0.42 · 2026-04-27

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

closed · Rounds: 4 · Score: 0.47 · 2026-04-27

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

closed · Rounds: 4 · Score: 0.52 · 2026-04-27

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

closed · Rounds: 4 · Score: 0.72 · 2026-04-27

What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transc

closed · Rounds: 4 · Score: 0.90 · 2026-04-03

Related Research

Hypotheses and analyses mentioning Inflammasome Complex in their description or question text

Galectin-3 deletion attenuates NLRP3 inflammasome activation downstream of lysos

Score: 0.625 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** Galectin-3 (LGALS3) functions as a critical molecular sensor and platform orchest

NLRP3 Inflammasome Priming Converts SCFA-Sensitive Pyroptosis into Chronic IL-1β

Score: 0.620 · neurodegeneration · 2026-04-26

Gut-derived bacterial components (LPS, MDP) provide Signal 1 for NLRP3 inflammasome priming via TLR4/TLR2/NOD2, inducing

Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 infla

Score: 0.620 · neuroscience · 2026-04-22

## Mechanistic Overview Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 inflammasome activati

NLRP3 Inflammasome Inhibition Prevents Synapse Loss via IL-1β Suppression

Score: 0.610 · neurodegeneration · 2026-04-28

NLRP3 inflammasome activation releases IL-1β, driving complement cascade upregulation and synapse elimination. MCC950 or

Intermittent HBOT (2.0 ATA, 60 min, 3x/week) suppresses NLRP3 inflammasome and s

Score: 0.590 · neurodegeneration · 2026-04-25

This hypothesis proposes that HBOT reduces ROS-mediated NF-κB activation and NLRP3 inflammasome assembly, promoting anti

NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumulation

Score: 0.566 · developmental-neurobiology · 2026-04-21

## Mechanistic Overview NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumulation starts from the claim that mod

NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplificati

Score: 0.566 · neurodegeneration · 2026-04-16

## Mechanistic Overview NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplification starts from t

P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming

Score: 0.563 · biomarkers · 2026-04-22

## Mechanistic Overview P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming starts from the claim that modulatin

TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inflammasome Regulation

Score: 0.485 · neuroinflammation · 2026-04-21

## Mechanistic Overview TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inflammasome Regulation starts from the

Sub-antidepressant Doses Suppress NLRP3 Inflammasome via P2X7 Receptor Blockade

Score: 0.465 · unknown disease · 2026-04-26

Trazodone acts as a weak antagonist at P2X7 purinergic receptors (IC50 ~3 micromolar), suppressing microglial NLRP3 infl

STING-Mediated NLRP3 Inflammasome Priming in ALS Microglia

Score: 0.380 · neuroinflammation · 2026-04-26

This hypothesis proposes that cytoplasmic mtDNA released from TDP-43-damaged mitochondria in ALS activates the cGAS-STIN

Circulating hs-CRP as Disease-Modifying Target via Astrocytic NLRP3 Inflammasome

Score: 0.380 · immunomics · 2026-04-27

Elevated circulating high-sensitivity C-reactive protein (hs-CRP) serves as a disease-modifying target through direct ac

NLRP3 Inflammasome Suppression via Selective Caspase-1 Inhibition

Score: 0.105 · neurodegeneration · 2026-04-18

## Mechanistic Overview NLRP3 Inflammasome Suppression via Selective Caspase-1 Inhibition starts from the claim that mod

Microglial NLRP3 Inflammasome as Circadian-Specific Drug Target

Score: 0.000 · unknown disease · 2026-04-28

The NLRP3 inflammasome exhibits circadian oscillations regulated by BMAL1-dependent acetylation. Selective microglial ta